Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Amir Sasan Mozaffari Nejad 3 Articles
The Occurrence and Risk Assessment of Exposure to Aflatoxin M1 in Ultra-High Temperature and Pasteurized Milk in Hamadan Province of Iran
Amir Sasan Mozaffari Nejad, Ali Heshmati, Tayebe Ghiasvand
Osong Public Health Res Perspect. 2019;10(4):228-233.   Published online August 31, 2019
DOI: https://doi.org/10.24171/j.phrp.2019.10.4.05
  • 7,207 View
  • 156 Download
  • 24 Crossref
AbstractAbstract PDF
Objectives

Aflatoxins are a category of poisonous compounds found in most plants, milk and dairy products. The present research was carried out to detect the presence of aflatoxin M1 (AFM1) in samples of milk collected from Hamadan province, Iran.

Methods

Twenty five samples of ultra-high temperature (UHT) and 63 samples of pasteurized milk were collected and the amount of AFM1 was measured by an Enzyme-Linked Immunosorbent Assay method. In addition, the estimated daily intake (EDI) and hazard index (HI) of AFM1 was determined by the following equations:(EDI= mean concentration of AFM1 × daily consumption of milk/body weight; HI= EDI/Tolerance Daily Intake).

Results

AFM1 was detected in 21 (84%) UHT milk samples and in 55 (87.30%) pasteurized milk samples. Seven (28%) samples of UHT and 21 (33.33%) pasteurized milk samples had higher AFM1 content than the limit allowed in the European Union and Iranian National Standard Limits (0.05 μg/kg). None of the samples exceeded the US Food and Drug Administration limit (0.5 μg/kg) for AFM1. EDI and HI for AM1 through milk were 0.107 ng/kg body weight/day, and 0.535, respectively.

Conclusion

A significant percentage of milk produced by different factories in Iran (84% of UHT and 87.3% of pasteurized milk) was contaminated with AFM1. Therefore, more control and monitoring of livestock feeding in dairy companies may help reduce milk contamination with AFM1. As the HI value was lower than 1, it can be assumed that there was no risk of developing liver cancer due to milk consumption.

Citations

Citations to this article as recorded by  
  • Seasonal variation and risk assessment of exposure to aflatoxin M1 in milk, yoghurt, and cheese samples from Ilam and Lorestan Provinces of Iran
    Kousar Aghebatbinyeganeh, Mohammadhosein Movassaghghazani, Mohamed Fathi Abdallah
    Journal of Food Composition and Analysis.2024; 128: 106083.     CrossRef
  • Review, meta-analysis and carcinogenic risk assessment of aflatoxin M1 in different types of milks in Iran
    Fatemeh Mortezazadeh, Fathollah Gholami-Borujeni
    Reviews on Environmental Health.2023; 38(3): 511.     CrossRef
  • Molecular identification and biocontrol of ochratoxigenic fungi and ochratoxin A in animal feed marketed in the state of Qatar
    Fatma Ali Alsalabi, Zahoor Ul Hassan, Roda F. Al-Thani, Samir Jaoua
    Heliyon.2023; 9(1): e12835.     CrossRef
  • Risk assessments for the dietary intake aflatoxins in food: A systematic review (2016–2022)
    Kiran Bhardwaj, Julie P. Meneely, Simon A. Haughey, Moira Dean, Patrick Wall, Guangtao Zhang, Bob Baker, Christopher T. Elliott
    Food Control.2023; 149: 109687.     CrossRef
  • A systematic literature review for aflatoxin M1 of various milk types in Iran: Human health risk assessment, uncertainty, and sensitivity analysis
    Tooraj Massahi, Amir Kiani, Kiomars Sharafi, Behzad Karami Matin, Abdullah Khalid Omer, Gholamreza Ebrahimzadeh, Jalil Jaafari, Nazir Fattahi
    Food Control.2023; 150: 109733.     CrossRef
  • The occurrence of aflatoxin M1 in milk samples of Iran: a systematic review and meta-analysis
    Neda Mollakhalili-Meybodi, Amene Nematollahi
    Environmental Monitoring and Assessment.2023;[Epub]     CrossRef
  • Effect of basil seed and xanthan gum on physicochemical, textural, and sensory characteristics of low‐fat cream cheese
    Jalal Portaghi, Ali Heshmati, Mehdi Taheri, Ebrahim Ahmadi, Amin Mousavi Khaneghah
    Food Science & Nutrition.2023; 11(10): 6060.     CrossRef
  • Evaluation of aflatoxin M1 content in milk and dairy products by high-performance liquid chromatography in Tehran, Iran
    Nazanin SHABANSALMANİ, Mohammadhosein MOVASSAGHGHAZANİ
    Harran Tarım ve Gıda Bilimleri Dergisi.2023; 27(3): 435.     CrossRef
  • Seasonal Study of Aflatoxin M1 Contamination in Cow Milk on the Retail Dairy Market in Gorgan, Iran
    Hadi Rahimzadeh Barzoki, Hossein Faraji, Somayeh Beirami, Fatemeh Zahra Keramati, Gulzar Ahmad Nayik, Zahra Izadi Yazdanaabadi, Amir Sasan Mozaffari Nejad
    Dairy.2023; 4(4): 571.     CrossRef
  • Aflatoxin M1 in milk and dairy products: global occurrence and potential decontamination strategies
    Khurram Muaz, Muhammad Riaz, Carlos Augusto Fernandes de Oliveira, Saeed Akhtar, Shinawar Waseem Ali, Habibullah Nadeem, Sungkwon Park, Balamuralikrishnan Balasubramanian
    Toxin Reviews.2022; 41(2): 588.     CrossRef
  • Feed to fork risk assessment of mycotoxins under climate change influences - recent developments
    Rhea Sanjiv Chhaya, John O'Brien, Enda Cummins
    Trends in Food Science & Technology.2022; 126: 126.     CrossRef
  • The behavior of aflatoxin M1 during lactic cheese production and storage
    Mahtab Einolghozati, Ali Heshmati, Freshteh Mehri
    Toxin Reviews.2022; 41(4): 1163.     CrossRef
  • Exposure assessment on aflatoxin M1 from milk and dairy products-relation to public health
    Eleni Malissiova, Georgia Soultani, Konstantina Tsokana, Mary Alexandraki, Athanasios Manouras
    Clinical Nutrition ESPEN.2022; 47: 189.     CrossRef
  • Aflatoxin M1 in distributed milks in northwestern Iran: occurrence, seasonal variation, and risk assessment
    Seyyed Ahmad Mokhtari, Ali Nemati, Mehdi Fazlzadeh, Eslam Moradi-Asl, Vahid Taefi Ardabili, Anoshirvan Seddigh
    Environmental Science and Pollution Research.2022; 29(27): 41429.     CrossRef
  • Brucellosis in Humans with the Approach of Brucella Species Contamination in Unpasteurized Milk and Dairy Products from Hamadan, Iran
    Mohammad Mahdi Majzobi, Pejman Karami, Amir Khodavirdipour, Mohammad Yousef Alikhani
    Iranian Journal of Medical Microbiology.2022; 16(4): 282.     CrossRef
  • Probabilistic modeling and risk characterization of the chronic aflatoxin M1 exposure of Hungarian consumers
    Zsuzsa Farkas, Kata Kerekes, Árpád Ambrus, Miklós Süth, Ferenc Peles, Tünde Pusztahelyi, István Pócsi, Attila Nagy, Péter Sipos, Gabriella Miklós, Anna Lőrincz, Szilveszter Csorba, Ákos Bernard Jóźwiak
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • The occurrence of aflatoxin M1 in doogh, kefir, and kashk in Hamadan, Iran
    Mina KHORSHIDI, Ali HESHMATI, Zahra HADIAN, Slim SMAOUI, Amin MOUSAVI KHANEGHAH
    Food Science and Technology.2022;[Epub]     CrossRef
  • Characterization and mechanism of aflatoxin degradation by a novel strain of Trichoderma reesei CGMCC3.5218
    Xiaofeng Yue, Xianfeng Ren, Jiayun Fu, Na Wei, Claudio Altomare, Miriam Haidukowski, Antonio F. Logrieco, Qi Zhang, Peiwu Li
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Simultaneous multi-determination of pesticide residues in black tea leaves and infusion: a risk assessment study
    Ali Heshmati, Fereshteh Mehri, Amin Mousavi Khaneghah
    Environmental Science and Pollution Research.2021; 28(11): 13725.     CrossRef
  • Development of a specific anti-idiotypic nanobody for monitoring aflatoxin M1 in milk and dairy products
    Chong Cai, Qi Zhang, Seyni Nidiaye, Honglin Yan, Wen Zhang, Xiaoqian Tang, Peiwu Li
    Microchemical Journal.2021; 167: 106326.     CrossRef
  • Prevalence of aflatoxin M1 in pasteurized and ultra-high temperature (UHT) milk marketed in Dar es Salaam, Tanzania
    F. Mwakosya Hilda, K. Mugula Jovin
    African Journal of Microbiology Research.2021; 15(9): 461.     CrossRef
  • Multi-mycotoxin occurrence in feed, metabolism and carry-over to animal-derived food products: A review
    J. Tolosa, Y. Rodríguez-Carrasco, M.J. Ruiz, P. Vila-Donat
    Food and Chemical Toxicology.2021; 158: 112661.     CrossRef
  • Presence of Aflatoxin M1 in Commercial Milk in Paraguay
    Andrea Alejandra Arrúa, Pablo David Arrúa, Juliana Moura-Mendes, Cinthia Cazal, Francisco Paulo Ferreira, Cristhian Javier Grabowski, Horacio Daniel Lopez-Nicora, Danilo Fernández Rios
    Journal of Food Protection.2021; 84(12): 2128.     CrossRef
  • The Occurrence and Risk Assessment of Aflatoxin M1 in Yoghurt Samples from Hamadan, Iran
    Ali Heshmati, Amir Sasan Mozaffari Mozaffari Nejad, Tayebeh Ghyasvand
    The Open Public Health Journal.2020; 13(1): 512.     CrossRef
Natural Infection with Rabies Virus: A Histopathological and Immunohistochemical Study of Human Brains
Firouzeh Farahtaj, Leila Alizadeh, Alireza Gholami, Alireza Tahamtan, Sadegh Shirian, Maryam Fazeli, Amir Sasan Mozaffari Nejad, Ali Gorji, Hamid Mahmoudzadeh Niknam, Amir Ghaemi
Osong Public Health Res Perspect. 2019;10(1):6-11.   Published online February 28, 2019
DOI: https://doi.org/10.24171/j.phrp.2019.10.1.03
  • 7,632 View
  • 257 Download
  • 12 Crossref
AbstractAbstract PDF
Objectives

Despite all the efforts and increased knowledge of rabies, the exact mechanisms of infection and mortality from the rabies virus are not well understood. To understand the mechanisms underlying the pathogenicity of rabies virus infection, it is crucial to study the tissue that the rabies virus naturally infects in humans.

Methods

Cerebellum brain tissue from 9 human post mortem cases from Iran, who had been infected with rabies virus, were examined histopathologically and immunohistochemically to evaluate the innate immune responses against the rabies virus.

Results

Histopathological examination revealed inflammation of the infected cerebellum and immunohistochemical analyses showed an increased immunoreactivity of heat shock protein 70, interleukin-6, interleukin-1, tumor necrosis factor-alpha, caspase-3, caspase-9, toll-like receptor3 and toll-like receptor4 in the infected brain tissue.

Conclusion

These results indicated the involvement of innate immunity in rabies infected human brain tissue, which may aggravate the progression of this deadly disease.

Citations

Citations to this article as recorded by  
  • Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection
    Prapimpun Wongchitrat, Theerawut Chanmee, Piyarat Govitrapong
    Molecular Neurobiology.2024; 61(5): 2881.     CrossRef
  • Systematic development of immunohistochemistry protocol for large cryosections-specific to non-perfused fetal brain
    Karthika Pandurangan, Jaikishan Jayakumar, Stephen Savoia, Reetuparna Nanda, S. Lata, E. Harish Kumar, Suresh S., Sudha Vasudevan, Chitra Srinivasan, Jayaraj Joseph, Mohanasankar Sivaprakasam, Richa Verma
    Journal of Neuroscience Methods.2024; 405: 110085.     CrossRef
  • Biosensor as an alternative diagnostic method for rabies virus detection: A literature review
    Milad Zandi, Sajad Zandi, Ramin Mohammadi, Parastoo Hosseini, Samane Teymouri, Saber Soltani, Azadeh Rasouli
    Biotechnology and Applied Biochemistry.2022; 69(4): 1348.     CrossRef
  • Immunohistochemical diagnosis of human infectious diseases: a review
    Hamadou Oumarou Hama, Gérard Aboudharam, Rémi Barbieri, Hubert Lepidi, Michel Drancourt
    Diagnostic Pathology.2022;[Epub]     CrossRef
  • Mitochondrial Dysfunction in Rabies Virus-Infected Human and Canine Brains
    Pulleri Kandi Harsha, Sathyanarayanan Ranganayaki, Gowri Yale, Gourav Dey, Kiran K. Mangalaparthi, Anusha Yarlagadda, B. K. Chandrasekhar Sagar, Anita Mahadevan, M. M. Srinivas Bharath, Reeta S. Mani
    Neurochemical Research.2022; 47(6): 1610.     CrossRef
  • A rare fatal case of rabies coexisting with COVID-19
    RabiNarayan Hota, Shalendra Singh, Rakesh Sharma, Pallavi Khandare
    Journal of Acute Disease.2022; 11(3): 129.     CrossRef
  • Enhancement of immune responses by co-stimulation of TLR3 - TLR7 agonists as a potential therapeutics against rabies in mouse model
    Firouzeh Farahtaj, Alireza Gholami, Mohammad Sadeq Khosravy, Safoora Gharibzadeh, Hamid Mahmoudzadeh Niknam, Amir Ghaemi
    Microbial Pathogenesis.2021; 157: 104971.     CrossRef
  • Establishment of Human-Induced Pluripotent Stem Cell-Derived Neurons—A Promising In Vitro Model for a Molecular Study of Rabies Virus and Host Interaction
    Thanathom Chailangkarn, Nathiphat Tanwattana, Thanakorn Jaemthaworn, Sira Sriswasdi, Nanchaya Wanasen, Sithichoke Tangphatsornruang, Kantinan Leetanasaksakul, Yuparat Jantraphakorn, Wanapinun Nawae, Penpicha Chankeeree, Porntippa Lekcharoensuk, Boonlert L
    International Journal of Molecular Sciences.2021; 22(21): 11986.     CrossRef
  • Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections
    Malgorzata Ciurkiewicz, Vanessa Herder, Andreas Beineke
    International Journal of Molecular Sciences.2020; 21(5): 1705.     CrossRef
  • Characterization of the Th17 profile immune response in cases of human rabies transmitted by dogs and its interference in the disease pathogenesis.
    L.B. Santos, F. Guedes, S.M. Achkar, M.I.S. Duarte, I.S.S. Katz, S.R. Silva, E.R. Fernandes
    Journal of Neuroimmunology.2020; 344: 577263.     CrossRef
  • Quantitative proteomics leads to identify dog brain proteins involved in rabies virus infection: implication in understanding viral pathophysiology
    Suchismita Behera, Rajesh Raghunath Pharande, R. Rajendra Reddy, Sharmila B. Majee, Sandeepan Mukherjee, Amol Ratnakar Suryawanshi
    Journal of Proteins and Proteomics.2020; 11(4): 241.     CrossRef
  • Feral dog bite causing paralytic rabies: Difficult diagnosis and failure of prevention
    Hussein Algahtani, Bader Shirah, Emna Chtourou, Osama Abuhawi, Nawal Abdelghaffar, Mohammad Alshehri
    Saudi Journal for Health Sciences.2020; 9(3): 260.     CrossRef
Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications
Mohammad Haghighatpanah, Amir Sasan Mozaffari Nejad, Maryam Haghighatpanah, Girish Thunga, Surulivelrajan Mallayasamy
Osong Public Health Res Perspect. 2018;9(4):167-174.   Published online August 31, 2018
DOI: https://doi.org/10.24171/j.phrp.2018.9.4.05
  • 9,178 View
  • 164 Download
  • 57 Crossref
AbstractAbstract PDF
Objectives

Inadequate glycemic control amongst patients with Type 2 diabetes mellitus (T2DM) indicates a major public health problem and a significant risk factor for the progression and complications caused by diabetes. Glycemic control is the main therapeutic objective for the prevention of organ damage and other complications arising from diabetes.

Methods

This was a retrospective observational study of T2DM patients with complications, who were aged 40 years and older. The study was conducted retrospectively on medical records (in-patient and out-patient) obtained from a South Indian teaching hospital, Manipal, India. The patients included in the study had fasting blood sugar, postprandial blood sugar and HbA1c measured at least twice during follow-ups the previous year. Patients’ HbA1c levels were categorized into good control ≤7% (≤53mmol/mol), and poor control >7% (>53mmol/mol), and patients’ characteristics were analyzed.

Results

A total of 657 patients were included in the study. The mean age was 59.67 (SD = 9.617) years, with 152 (23.1%) females and 505 (76.9%) males, and 514 (78.2%) patients had poor glycemic control. Most of the patients were on insulin mono-therapy [n = 271 (42.1%)], about a third of the patients were on combination therapy that included an oral hypoglycemic agent and insulin [n = 236 (36.6%)]. Patients with a history of more than 10 years of diabetes [n = 293 (44.6%)], had a family history of diabetes [n = 256 (39%)] and obesity [n = 95 (14.5%)], all had poor glycemic control.

Conclusion

This present study indicated a significant association of gender (female), age, high-density lipoprotein level, duration of diabetes and type of medication, with poor glycemic control in T2DM patients that had secondary medical complications.

Citations

Citations to this article as recorded by  
  • Effectiveness of Family-Based Diabetes Management Intervention on Glycated Haemoglobin Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Margareta Teli, Ratsiri Thato, Faizul Hasan, Yohanes Andy Rias
    Biological Research For Nursing.2024; 26(2): 315.     CrossRef
  • Factors linked to poor glycemic control in an outpatient diabetic clinic: a cross-sectional study in Saint-Nicolas Hospital, Haiti
    Ludentz Dorcélus, Emmanuel R. Alexandre, Charnee M. Villemenay, Scaïde U. Benjaminel, Eddie Charles
    Journal of Global Health Reports.2024;[Epub]     CrossRef
  • The prevalence of hypogonadism in male patients with type 2 diabetes mellitus and clinically relevant factors
    Hakan DÜĞER
    Journal of Health Sciences and Medicine.2024; 7(1): 53.     CrossRef
  • Real-world effectiveness of iGlarLixi in individuals with T2D sub-optimally controlled on oral anti-diabetic drugs with or without basal insulin in daily practice in Saudi Arabia (EMPOWER study)
    Anwar Jammah, Nagwa Roushdy, Mohamed Gamil, Nidal Abu Diab, Naglaa Abdelmonaem, Saher Safarini, Mohamed Gadallah, Nedal Abu Zaid, Yahya Shihadeh, Mohamed Saeed, Jamaa Sadik, Yasser Akil
    Endocrine and Metabolic Science.2024; 15: 100164.     CrossRef
  • Rejuvenating Mobility: Impact of Concurrent Exercise on Functional Claudication Distance and Vascular Health among Patients with T2DM-Associated PAD
    Uroosa Amin, Qurat-ul-Ain Adnan, Dr. Tauseef Ahmad
    Allied Medical Research Journal.2024; : 138.     CrossRef
  • Exploring the Interplay of Socioeconomic and Behavioral Factors: Unraveling Gender Disparities in Glycemic Control Among Adult Type 2 Diabetic Patients in Outpatient Care
    Amar Mankar, Umesh Kawalkar, Nilesh Jadhao, Umesh Joge, Ashutosh Paldiwal, Manoj Talapalliwar, Manoj S Patil
    Cureus.2024;[Epub]     CrossRef
  • Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population
    Ambily Sivadas, S Sahana, Bani Jolly, Rahul C Bhoyar, Abhinav Jain, Disha Sharma, Mohamed Imran, Vigneshwar Senthivel, Mohit Kumar Divakar, Anushree Mishra, Arpita Mukhopadhyay, Greg Gibson, KM Venkat Narayan, Sridhar Sivasubbu, Vinod Scaria, Anura V Kurp
    BMJ Open Diabetes Research & Care.2024; 12(2): e003769.     CrossRef
  • Prevalence of and factors associated with suboptimal glycemic control among patients with type 2 diabetes mellitus attending public hospitals in the Greater Male’ Region, Maldives: a hospital-based cross-sectional study
    Jeehana Shareef, Tawatchai Apidechkul, Peeradone Srichan
    BMC Public Health.2024;[Epub]     CrossRef
  • Exploring the self-efficacy of patients with diabetes: its role as a predictor of diabetes management and well-being
    Ayoub Ali Alshaikh, Faisal Saeed Al-Qahtani, Saif Aboud M. Alqahtani, Ahmad Ali AlFarhan, Ali Mushabbab Al Nuwayhidh, Ayman Mohammed Madkhali, Riyad Saeed AlQahtani, Ali Fayez AlAsmari, Abdulaziz Saeed Alserhani, Hatim Ahmed Alqubaisi, Ziyad Saad Saeed Al
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: Unmatched case-control study
    Gebrehiwot Lema Legese, Getahun Asres, Shitaye Alemu, Tesfaye Yesuf, Yeabsira Aklilu Tesfaye, Tsegaw Amare
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis
    Zebenay Workneh Bitew, Ayinalem Alemu, Desalegn Abebaw Jember, Erkihun Tadesse, Fekadeselassie Belege Getaneh, Awole Seid, Misrak Weldeyonnes
    INQUIRY: The Journal of Health Care Organization, .2023; 60: 004695802311557.     CrossRef
  • Glycemic control and diabetes complications among adult type 2 diabetic patients at public hospitals in Hadiya zone, Southern Ethiopia
    Abraham Lomboro Dimore, Zerihun Kura Edosa, Asmelash Abera Mitiku, Suman S. Thakur
    PLOS ONE.2023; 18(3): e0282962.     CrossRef
  • Using Machine Learning for the Risk Factors Classification of Glycemic Control in Type 2 Diabetes Mellitus
    Yi-Ling Cheng, Ying-Ru Wu, Kun-Der Lin, Chun-Hung Lin, I-Mei Lin
    Healthcare.2023; 11(8): 1141.     CrossRef
  • Knowledge and Awareness About Diabetes Mellitus Among Urban and Rural Population Attending a Tertiary Care Hospital in Haryana
    Dr.Lalit Kumar, Rahul Mittal, Akhil Bhalla, Ashwani Kumar, Hritik Madan , Kushagra Pandhi, Yukta Garg, Kamaldeep Singh, Arpit Jain, Surya Rana
    Cureus.2023;[Epub]     CrossRef
  • Glycemic Control and Its associated Determinants among Type II Diabetic Patients at Tertiary Care Hospital in North India
    Soorvir singh Gurger, Anshu Mittal, Gauri shankar Goel, Anuj Mittal, Deepmala Kamboj
    Healthline.2023; 14(1): 17.     CrossRef
  • Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study
    Budi Suprapti, Zamrotul Izzah, Ade Giriayu Anjani, Mareta Rindang Andarsari, Wenny Putri Nilamsari, Cahyo Wibisono Nugroho
    Global Epidemiology.2023; 5: 100113.     CrossRef
  • The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia
    Phei Ching Lim, Hooi Hoon Tan, Nurul Ain Mohd Noor, Chee Tao Chang, Te Ying Wong, Ee Linn Tan, Chiou Ting Ong, Kalyhani Nagapa, Lee Shyong Tai, Wei Ping Chan, Yong Boey Sin, Yin Shan Tan, Shanty Velaiutham, Rohaizan Mohd Hanafiah
    Journal of Pharmaceutical Policy and Practice.2023;[Epub]     CrossRef
  • Early detection system of risk factors for diabetes mellitus type 2 utilization of machine learning-random forest
    Johannes B. Ginting, Tri Suci, Chrismis N. Ginting, Ermi Girsang
    Journal of Family and Community Medicine.2023; 30(3): 171.     CrossRef
  • Identifying Profiles of Patients With Uncontrolled Type 2 Diabetes Who Would Benefit From Referral to an Endocrinologist
    Eden Avnat, Gabriel Chodick, Varda Shalev
    Endocrine Practice.2023; 29(11): 855.     CrossRef
  • Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population
    Masoud Faghieh Dinavari, Sarvin Sanaie, Kimia Rasouli, Elnaz Faramarzi, Roghayeh Molani-Gol
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms
    Sandra A. Reza-López, Susana González-Gurrola, Oscar O. Morales-Morales, Janette G. Moreno-González, Ana M. Rivas-Gómez, Everardo González-Rodríguez, Verónica Moreno-Brito, Angel Licón-Trillo, Irene Leal-Berumen
    Biomolecules.2023; 13(12): 1791.     CrossRef
  • Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis
    Natthanicha Sauenram, Jutatip Sillabutra, Chukiat Viwatwongkasem, Pratana Satitvipawee
    Osong Public Health and Research Perspectives.2023; 14(6): 508.     CrossRef
  • What drives glycemic control in a person living with diabetes?
    Rajiv Singla, Geetu Gupta, Yashdeep Gupta
    International Journal of Diabetes in Developing Co.2022; 42(2): 369.     CrossRef
  • Prevalence and predictors of suboptimal glycemic control among patients with type 2 diabetes mellitus in northern Thailand: A hospital-based cross-sectional control study
    Fartima Yeemard, Peeradone Srichan, Tawatchai Apidechkul, Naphat Luerueang, Ratipark Tamornpark, Suphaphorn Utsaha, Sompop Bencharit
    PLOS ONE.2022; 17(1): e0262714.     CrossRef
  • Exploring of Determinants Factors of Anti-Diabetic Medication Adherence in Several Regions of Asia – A Systematic Review
    Much Ilham Novalisa Aji Wibowo, Nanang Munif Yasin, Susi Ari Kristina, Yayi Suryo Prabandari
    Patient Preference and Adherence.2022; Volume 16: 197.     CrossRef
  • Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study
    Mohammed Abdu Seid, Adugnaw Ambelu, Mengistie Diress, Yigizie Yeshaw, Yonas Akalu, Baye Dagnew
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • Relations of Well-Being, Coping Styles, Perception of Self-Influence on the Diabetes Course and Sociodemographic Characteristics with HbA1c and BMI Among People with Advanced Type 2 Diabetes Mellitus
    Agnieszka Łukasiewicz, Andrzej Kiejna, Ewelina Cichoń, Aleksandra Jodko-Modlińska, Marcin Obrębski, Andrzej Kokoszka
    Diabetes, Metabolic Syndrome and Obesity: Targets .2022; Volume 15: 407.     CrossRef
  • A bibliometric analysis of highly cited insulin resistance publications in Science Citation Index Expanded
    Yuh-Shan Ho, Priyanga Ranasinghe
    Obesity Medicine.2022; 31: 100399.     CrossRef
  • Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns
    Harmanjit Singh, Dinesh Joshi, Seerat Narula, Mandeep Singla, Ravi Rohilla, Jagjit Singh
    Expert Review of Clinical Pharmacology.2022; 15(2): 197.     CrossRef
  • Factors associated with Glycemic control among Syrian patients with Type 2 Diabetes Mellitus
    Khadija Khalil, Afraa Zrieki`
    Research Journal of Pharmacy and Technology.2022; : 1701.     CrossRef
  • A Comparative analysis of type 2 diabetes management quality indicators in cancer survivors
    Eun J. Ko, Su J. Lee
    Asia-Pacific Journal of Oncology Nursing.2022; 9(11): 100116.     CrossRef
  • Analysis of the Association between Metabolic Syndrome and Renal Function in Middle-Aged Patients with Diabetes
    Yoonjin Park, Su Jung Lee
    International Journal of Environmental Research an.2022; 19(18): 11832.     CrossRef
  • Effective data-driven precision medicine by cluster-applied deep reinforcement learning
    Sang Ho Oh, Su Jin Lee, Jongyoul Park
    Knowledge-Based Systems.2022; 256: 109877.     CrossRef
  • Management goal achievements of diabetes care in Iran: study profile and main findings of DiaCare survey
    Gita Shafiee, Safoora Gharibzadeh, Nekoo Panahi, Farideh Razi, Seyed Masoud Arzaghi, Vahid Haghpanah, Afshin Ostovar, Alireza Raeisi, Alireza Mahdavi-Hezareh, Bagher Larijani, Ensieh Nasli Esfahani, Ramin Heshmat
    Journal of Diabetes & Metabolic Disorders.2022; 22(1): 355.     CrossRef
  • Glycemic control and its determinants among people with type 2 diabetes mellitus in Ernakulam district, Kerala
    ShanaShirin Najeeb, TeenaMary Joy, Aswathy Sreedevi, K Vijayakumar, Syama, . Glycaemic Control and Determinants Team
    Indian Journal of Public Health.2022; 66(5): 80.     CrossRef
  • Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
    Hye Ah Lee, Hyesook Park, Young Sun Hong
    Diabetes & Metabolism Journal.2022; 46(6): 879.     CrossRef
  • Relationship and influences of behavioral and psychological factors on metabolic control of patients with type 2 diabetes mellitus
    Vojislav Stanojevic, Marija Jevtic, Milena Mitrovic, Marko Panajotovic, Aleksandar Aleksic, Cedomirka Stanojevic
    Vojnosanitetski pregled.2022; 79(12): 1177.     CrossRef
  • Lipid Profile and Glycemic Control in Type 2 Diabetic Patients
    Sarah Maan AL-Bahrani, Batool A.Gh. Yassin
    Arab Board Medical Journal.2022; 23(1): 21.     CrossRef
  • Glycemic Control of Diabetes Mellitus Patients in Referral Hospitals of Amhara Region, Ethiopia: A Cross-Sectional Study
    Berhanu Elfu Feleke, Teferi Elfu Feleke, Melkamu Beyene Kassahun, Wondemu Gebrekirose Adane, Netsanet Fentahun, Abel Girma, Alamirew Alebachew, Eyaya Misgan, Hanna Demelash Desyibelew, Mulat Tirfie Bayih, Omer Seid, Daniel Diaz
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Association of glycemic control and anthropometric measurement among type 2 diabetes mellitus: a cross-sectional study
    Mitku Mammo Taderegew, Mamo Solomon Emeria, Betregiorgis Zegeye
    Diabetology International.2021; 12(4): 356.     CrossRef
  • Impact of pharmacist-led educational intervention on predictors of diabetic foot at two different hospitals of Malaysia
    AmerHayat Khan, MuhammadZahid Iqbal, SyedAzhar Syed Sulaiman, Aznita Ibrahim, NorShaffinaz Binti Yusoff Azmi, MuhammadShahid Iqbal, AhmedA Albassam
    Journal of Pharmacy And Bioallied Sciences.2021; 13(1): 108.     CrossRef
  • Factors Associated with Glycaemic Control among Diabetic Patients Managed at an Urban Hospital in Hanoi, Vietnam
    Luu Quang Thuy, Hoang Thi Phuong Nam, Tran Thi Ha An, Bui Van San, Tran Nguyen Ngoc, Le Hong Trung, Pham Huy Tan, Nguyen Hoang Thanh, Everson A Nunes
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Predictors of Poor Plasma Glucose Maintenance in Type II Diabetic People with Ophthalmic Complication: The Case of Dessie Hospitals in Ethiopia
    Mohammed Abdu Seid, Baye Dagnew
    Diabetes, Metabolic Syndrome and Obesity: Targets .2021; Volume 14: 2317.     CrossRef
  • Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study
    Tae-Jin Song, Yoonkyung Chang, Jimin Jeon, Jinkwon Kim, David M. Ojcius
    PLOS ONE.2021; 16(6): e0253769.     CrossRef
  • Poor Glycemic Control and Its Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in East Ethiopia
    Tewodros Yosef, Dejen Nureye, Eyob Tekalign
    Diabetes, Metabolic Syndrome and Obesity: Targets .2021; Volume 14: 3273.     CrossRef
  • Probucol Pharmacological and Bio-Nanotechnological Effects on Surgically Transplanted Graft Due to Powerful Anti-Inflammatory, Anti-Fibrotic and Potential Bile Acid Modulatory Actions
    Armin Mooranian, Corina Mihaela Ionescu, Susbin Raj Wagle, Bozica Kovacevic, Daniel Walker, Melissa Jones, Jacqueline Chester, Thomas Foster, Edan Johnston, Momir Mikov, Marcus D. Atlas, Hani Al-Salami
    Pharmaceutics.2021; 13(8): 1304.     CrossRef
  • Clinical pharmacists education and counselling in patients with co-morbid hypertension and diabetes in a Municipal hospital in Ghana
    A. O. Kwakye, K. O. Buabeng, N. A. M. Opare-Addo, E. Owusu-Dabo
    African Journal of Pharmacy and Pharmacology.2021; 15(10): 183.     CrossRef
  • Effect of educational interventions on knowledge of the disease and glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials
    Wondimeneh Shibabaw Shiferaw, Tadesse Yirga Akalu, Melaku Desta, Ayelign Mengesha Kassie, Pammla Margaret Petrucka, Yared Asmare Aynalem
    BMJ Open.2021; 11(12): e049806.     CrossRef
  • Persistent Cardiometabolic Health Gaps: Can Therapeutic Care Gaps Be Precisely Identified from Electronic Health Records
    Xiaowei Yan, Walter F. Stewart, Hannah Husby, Jake Delatorre-Reimer, Satish Mudiganti, Farah Refai, Andrew Hudnut, Kevin Knobel, Karen MacDonald, Frangiscos Sifakis, James B. Jones
    Healthcare.2021; 10(1): 70.     CrossRef
  • Glycemic control and awareness of foot care indiabetic foot syndrome
    Ayten Guner Atayoglu, Ali Timucin Atayoglu, Rahime Ozgur, Hammad Khan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 200.     CrossRef
  • Раннє призначення інсуліну при цукровому діабеті 2-го типу: плюси і мінуси
    S.V. Jargin
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 169.     CrossRef
  • Salutogenic model of health to identify turning points and coping styles for eating practices in type 2 diabetes mellitus
    C. M. M. Polhuis, L. Vaandrager, S. S. Soedamah-Muthu, M. A. Koelen
    International Journal for Equity in Health.2020;[Epub]     CrossRef
  • Self-Care in Adults with Type 2 Diabetes Mellitus: A Systematic Review
    Rebeca Barbosa da Rocha, Cristiano Sales Silva, Vinícius Saura Cardoso
    Current Diabetes Reviews.2020; 16(6): 598.     CrossRef
  • Medication adherence assessment among patients with type 2 diabetes mellitus treated polytherapy in indonesian community health center: A cross sectional-study
    Nora Wulandari, Maifitrianti Maifitrianti, Faridlatul Hasanah, Sri Atika, Risa Dini Putri
    Journal of Pharmacy And Bioallied Sciences.2020; 12(6): 758.     CrossRef
  • Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming  Co-Epidemics


    Tsegaye Melaku, Legese Chelkeba, Zeleke Mekonnen, Kabaye Kumela
    Diabetes, Metabolic Syndrome and Obesity: Targets .2020; Volume 13: 4379.     CrossRef
  • Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes
    Suhrin Lee, SeungHwan Lee, In-Jin Jang, Kyung-Sang Yu, Su-jin Rhee
    Translational and Clinical Pharmacology.2020; 28(4): 199.     CrossRef
  • Poor-Glycaemic-Control Prevalence and Determinants among Type 2 Diabetes Mellitus Patients Attending a Primary Health Care Setting in Central Kerala
    Sajith Kumar Soman, Binu Areekal, Sudhiraj Thiruthara Sukumaran, Safa Puliyakkadi, Rajesh Koothupalakkal Ravi
    Journal of Evidence Based Medicine and Healthcare.2020; 7(49): 2892.     CrossRef

PHRP : Osong Public Health and Research Perspectives